Sort
39,280 grants matching “leukemia”
Assessment of DCAF15 role in Acute Myeloid Leukemia
$483,760Luca Busino · University Of Pennsylvania · R01 · FY2025 · CA
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2018 · OD
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2019 · OD
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2022 · OD
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2020 · OD
Targeting crotonyl-lysine chromatin readers to disrupt pathogenic gene expression in leukemia
$483,750Michael A Erb · Scripps Research Institute, The · DP5 · FY2021 · OD
Project 2: Combined CAR-T cell therapy
$483,710Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA
Implications of PARP1 in myelodysplastic syndromes and targeted therapy
$483,623Dang Hai Nguyen · University Of Minnesota · R01 · FY2023 · HL
Amotosalen PCT of Leukapheresis Units for GvHD Therapy
$483,547John Eugene Hearst · Transfusion And Transplantation Tech · R42 · FY2008 · HL
Myeloid Tumor Suppressor Gene Discovery from Chromosome Band 7q22
$483,413Kevin M Shannon · University Of Chicago · P01 · FY2010 · CA
HMGA Chromatin Remodeling Proteins in Tumor Progression in Myeloproliferative Neoplasms (MPN)
$483,395Linda M S Resar · Johns Hopkins University · R01 · FY2019 · HL
ALDH Activation to treat Fanconi Anemia
$483,345Kenneth I. Weinberg · Stanford University · R01 · FY2020 · HL
Longitudinal Tumor Monitoring with Nanodevices
$483,318Andrew Kummel · University Of California, San Diego · U54 · FY2008 · CA
Targeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms
$483,261Gary W Reuther · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · HL
Dissecting the Functional Role of PAX5 Mutations in B-cell Acute Lymphoblastic Leukemia
$483,110Zhaohui Gu · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES
$483,061John C Byrd · Ohio State University · P01 · FY2011 · CA
Development Of P2Y Receptor Ligands
$483,051Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Integrating Epidemiologic and Genomic Data to Elucidate the Genetic Overlap Between Congenital Anomalies and Pediatric Cancer
$483,022Chad Daniel Huff · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Meis1 Negatively Regulates Blood Flow in Hindlimb Ischemia
$483,000Jia-Qiang He · Virginia Polytechnic Inst And St Univ · R15 · FY2018 · HL
Competing Supplement for CLL Research Consortium
$482,989University Of California San Diego · P01 · FY2003 · CA
Novel Approaches to GHVD Prevention
$482,982Joseph H Antin · Dana-Farber Cancer Inst · P01 · FY2007 · HL
Control Of G Protein Signaling: Role Of The RGSs
$482,966John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-operative Treatment Trials
$482,956Nola M. Hylton · University Of California, San Francisco · R01 · FY2008 · CA
Genetic analysis of mouse chromosome 11
$482,909Monica Jean Justice · Baylor College Of Medicine · R01 · FY2010 · CA
NCTN Deep South Research Consortium
$482,879Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2020 · CA